Maximize Your Investment Potential: Expert Investor Counsel Urges Fulcrum Therapeutics Inc. Shareholders to Take Action Before June 27 Deadline in Securities Class Action Lawsuit
ROSEN Law Firm Urges Fulcrum Therapeutics Investors to Act Before June 27 Deadline June 13, 2023 NEW YORK (GLOBE NEWSWIRE) — ROSEN Law Firm, a renowned global investor rights law firm, is reminding investors who purchased securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) during the Class Period between March 3, 2022 and March 8, 2023,…